Population pharmacokinetics of mycophenolate in patients treated for interstitial lung disease (EVER-ILD study).

Yan-Min XuDavid TernantMartine Reynaud-GaubertThéodora Bejan-AngoulvantSylvain Marchand-Adam

Published in: Fundamental & clinical pharmacology (2024)

This is the first study reporting MPA pharmacokinetics in ILD. This pharmacokinetics appears to be similar to other indications and should be further investigated in future studies.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
emergency department
mass spectrometry
atomic force microscopy